Related Experiment Video
Updated: Feb 1, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Evaluating cytotoxic effects of recombinant fragaceatoxin C pore forming toxin against AML cell lines
Mahnaz Azadpour1,2, Maedeh Karimian1, Mohammad Hassan Kheirandish1
1Protein Engineering Laboratory, Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Objectives:
Current therapeutic strategies for cancer are associated with side effects and lack of specificity in treatments. Biological therapies including monoclonal antibodies and immune effectors have been the subject of multiple research projects. Pore-forming proteins may become the other biological strategy to overcome the problems associated with current treatments. But detailed mechanisms of their action on target membranes remained to be elucidated. We aimed to study the cytotoxic effects of recombinant form of fragaceatoxin C on AML cell lines HL-60 and KG-1.
Materials And Methods:
We cloned the FraC gene in pET-28a (+) bacterial expression vector and the expressed recombinant FraC protein was purified by affinity chromatography. Then, cytotoxic effects of the recombinant protein were examined on two AML cell lines, HL-60 and KG-1. Effects of serum and calcium ion were explored by hemolysis assay in more details.
Results:
Our results showed that the recombinant C-terminal polyhistidine-tagged FraC protein has potent cytotoxic effects on both AML cell lines, with IC50=5.6, and 4.6 µg.ml-1 for HL-60 and KG-1 cells, respectively. Serum showed dose-dependent and also time-dependent inhibitory effects on the hemolytic and cytotoxic activities of the FraC protein. Pre-incubation of the toxin with different concentrations of calcium ion also inhibited hemolytic activity of FraC toxin.
Conclusion:
Results of the present study showed that FraC has potential anti-tumor effects. By detailed investigation of the inhibition mechanism of serum and calcium effects in the future, it can be possible to design target sites for clinical applications of the toxin.
Insights
Fragaceatoxin C (FraC) exhibits potent cytotoxic effects against acute myeloid leukemia (AML) cell lines. Serum and calcium ions inhibit FraC
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Current cancer therapies face challenges with side effects and specificity.
- Biological therapies, including pore-forming proteins, offer potential alternative strategies.
- Understanding the mechanisms of pore-forming proteins on target membranes is crucial.
Purpose of the Study:
- To investigate the cytotoxic effects of recombinant fragaceatoxin C (FraC) on acute myeloid leukemia (AML) cell lines.
- To elucidate the influence of serum and calcium ions on FraC's activity.
Main Methods:
- Cloning and expression of the FraC gene in a bacterial vector.
- Purification of recombinant FraC protein using affinity chromatography.
- Assessment of cytotoxic effects on HL-60 and KG-1 AML cell lines.
- Hemolysis assays to study serum and calcium ion effects.
Main Results:
- Recombinant FraC demonstrated potent cytotoxic effects on both HL-60 and KG-1 cells (IC50 values of 5.6 and 4.6 µg/mL, respectively).
- Serum exhibited dose- and time-dependent inhibition of FraC's hemolytic and cytotoxic activities.
- Calcium ions also inhibited the hemolytic activity of FraC.
Conclusions:
- Recombinant FraC shows potential as an anti-tumor agent.
- Further research into the inhibition mechanisms by serum and calcium could inform clinical applications.
- FraC represents a promising biological strategy for cancer treatment.
Related Concept Videos
Cell Lines
Viral Recombination
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Homologous Recombination
Recombinant DNA
Pore Size Distribution
Adequate...

